The president said he would nominate Dr. Heidi Overton to lead the Food and Drug Administration. Some senators said they will not confirm her, saying she's unqualified and too conservative.
Copyright 2026 NPR
Sydney Lupkin
Sydney Lupkin is the pharmaceuticals correspondent for NPR, where she has reported on accelerated drug approvals whose confirmatory trials were overdue, Operation Warp Speed contract accountability, and the ripple effects of obesity drug shortages.